Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lumiracoxib versus ibuprofen blood pressure profile study in osteoarthritis patients with controlled hypertension
2005-003286-17Phase 4Completed
- Sponsor
- Novartis
- Start
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in osteoarthritis (OA) comparing Lumiracoxib arm with Ibuprofen arm (2 arms). Primary endpoint: Change from baseline in average 24-hour ambulatory systolic blood pressure at week 4. Started Oct 2005; status: completed.
02
Drugs
lumiracoxibibuprofen
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on 2005-003286-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003286-17.